Category: GLOBE-NEWSWIRE

BASF Environmental Catalyst and Metal Solutions inaugure un nouvel investissement dans l’hydrogène vert à Budenheim, en Allemagne

July 11, 2024

La nouvelle installation produira des composants pour l’électrolyse et les piles à combustible afin de soutenir la transition énergétique mondiale La production devrait commencer à l’été 2025 Investissement conjoint avec d’autres partenaires BUDENHEIM, Allemagne, 11 juill. 2024 (GLOBE NEWSWIRE) — BASF Environmental Catalyst and Metal Solutions (ECMS) a entamé la construction de sa première installation de […]

Read More

BASF Environmental Catalyst and Metal Solutions breaks ground on new green hydrogen investment in Budenheim, Germany

July 10, 2024

Groundbreaking of new green hydrogen production facility in Budenheim, Germany Pictured left to right: Dr. Günter Krummel, Gesellschafter Trigona FCC; André Semann, CFO Budenheim; Meaghan McGuire, Head of Strategic Marketing, Hydrogen, BASF ECMS; Tim Ingle, SVP Precious Metal Services and Recycling, BASF ECMS; Saeed Alerasool, SVP R&D and Application, BASF ECMS; Daniel Malko, Head of […]

Read More

Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

July 10, 2024

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable contributions to the industry. Campaign […]

Read More

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

July 4, 2024

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

Recent Posts

Ganzourgou CCP Reviews To¨ga Mine Progress and New Legal Texts

August 19, 2026

Ouagadougou: The Ganzourgou Provincial Consultation Framework (CCP) held its initial ordinary session of the year on Tuesday, August 18, 2026, in Zorgho, centering discussions on the progress of the To¨ga SA gold mining project and recent innovations …

Our Pages